Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
11
-
Total shares
-
304K
-
Shares change
-
+61.3K
-
Total reported value, excl. options
-
$266K
-
Value change
-
+$53K
-
Number of buys
-
5
-
Number of sells
-
-1
-
Price
-
$0.90
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q1 2019
11 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q1 2019.
iBio, Inc. - Common Stock (IBIO) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 304K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (128K shares), CITADEL ADVISORS LLC (53.2K shares), GEODE CAPITAL MANAGEMENT, LLC (34.3K shares), Virtu Financial LLC (17.6K shares), BlackRock Inc. (17.4K shares), TWO SIGMA SECURITIES, LLC (17.2K shares), NORTHERN TRUST CORP (14.3K shares), HighTower Advisors, LLC (10K shares), UBS Group AG (8.65K shares), and ROYAL BANK OF CANADA (2K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.